Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Metabolic and Cardiovascular Effects of a Proprietary Nutraceutical Containing Berberine, Policosanols and Red Yeast in Subjects With Metabolic Syndrome

NCT02295176 is registered in ClinicalTrials.gov with Rottapharm as lead sponsor.

NCT NCT02295176
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02295176 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Metabolic and Cardiovascular Effects of a Proprietary Nutraceutical Containing Berberine, Policosanols and Red Yeast in Subjects With Metabolic Syndrome
Lead sponsor
Rottapharm
Phase
Not applicable
Overall status
Completed
Start date
April 30, 2013
Completion date
July 31, 2015
Enrollment
159 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

insulin-resistance, left ventricular hypertrophy, metabolic syndrome